Glaucoma Drainage Devices Market Report 2026

Glaucoma Drainage Devices Market Overview

• Glaucoma Drainage Devices market size has reached to $0.89 billion in 2025 • Expected to grow to $1.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Rising Glaucoma Prevalence Fuels Growth In The Market • Market Trend: Advancements In Canal-Based Glaucoma Surgery Devices For Minimally Invasive Treatment Options • North America was the largest region in 2025.

What Is Covered Under Glaucoma Drainage Devices Market?

Glaucoma drainage devices are surgical implants designed to reduce intraocular pressure in patients with glaucoma. These devices provide a controlled outflow of aqueous humor from the eye, helping to prevent optic nerve damage. They are typically used when other treatments, such as medication or laser therapy, are insufficient. The main product types of glaucoma drainage devices are valved glaucoma drainage devices and non-valved glaucoma drainage devices. Valved glaucoma drainage devices are implantable devices with a one-way valve that regulate aqueous humor flow to reduce intraocular pressure (IOP) in refractory glaucoma patients, minimizing the risk of hypotony. It is applicable in several surgery types, such as conventional glaucoma surgery, minimally invasive glaucoma surgery, and is used by various end users, including hospitals, specialty clinics, ambulatory surgical centers, and others.

What Is The Glaucoma Drainage Devices Market Growth Forecast?

The glaucoma drainage devices market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive eye surgeries, rising investments in ophthalmic device innovation, expansion of advanced glaucoma care programs, growing focus on early intervention, technological advancements in implant materials and design. Major trends in the forecast period include increasing adoption of minimally invasive glaucoma implants, rising demand for valved drainage devices, growing focus on long-term intraocular pressure control, expansion of advanced biocompatible materials, enhanced precision in surgical implant design.

Global Glaucoma Drainage Devices Market Segmentation

1) By Product Type: Valved Glaucoma Drainage Devices, Non-Valved Glaucoma Drainage Devices 2) By Surgery Type: Conventional Glaucoma Surgery, Minimally Invasive Glaucoma Surgery 3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Valved Glaucoma Drainage Devices: Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant, Krupin Implant, Others 2) By Non-Valved Glaucoma Drainage Devices: Molteno Implant, Schocket Implant, Foster Implant, Others

What Are The Drivers Of The Glaucoma Drainage Devices Market?

The increasing prevalence of glaucoma conditions is expected to propel the growth of the glaucoma drainage devices market going forward. Glaucoma encompasses a group of eye disorders that damage the optic nerve, typically due to increased intraocular pressure, potentially resulting in vision loss if not addressed. The rising cases of glaucoma can be attributed to several factors, such as an aging population, urbanization, and lifestyle changes. Glaucoma drainage devices help manage intraocular pressure in refractory glaucoma by facilitating aqueous humor outflow when conventional treatments fail. For instance, in October 2025, according to the The NHS Confederation, a UK-based membership organization reported that glaucoma, the main cause of irreversible sight loss in the UK, affects over 700,000 people, nearly half of whom remain undiagnosed due to its symptomless nature and long hospital waits. NHS waiting times can reach 72 weeks, and major eye conditions are projected to rise 25% from 2022–2032, outpacing population growth sevenfold. Therefore, the increasing prevalence of glaucoma conditions is driving the growth of the glaucoma drainage devices industry. The expansion in healthcare infrastructure is expected to propel the growth of the glaucoma drainage devices market going forward. Healthcare infrastructure refers to the network of hospitals, clinics, diagnostic centers, and supporting medical facilities that provide access to quality healthcare services for the population. The expansion of healthcare infrastructure is driven by increasing government and private sector investments, rising population, and growing demand for advanced medical care. Improved infrastructure supports the adoption of new medical technologies, increases patient access to care, and enhances the efficiency of healthcare delivery. For instance, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, the expansion in healthcare infrastructure is driving growth in the glaucoma drainage devices industry.

Key Players In The Global Glaucoma Drainage Devices Market

Major companies operating in the glaucoma drainage devices market are AbbVie Inc., Alcon Inc., Johnson And Johnson Vision Care Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, Ocular Therapeutix Inc., IRIDEX Corporation, New World Medical Inc., Ivantis Inc., iSTAR Medical, Nova Eye Medical Limited, Altomed, Aurolab, G.surgiwear Limited, Eagle Vision Inc., Advanced Ophthalmic Innovations Pte Ltd., Avisi Technologies Inc., iVeena Delivery Systems, Optonol Ltd., Rheon-medical

Global Glaucoma Drainage Devices Market Trends and Insights

Major companies operating in the glaucoma drainage devices market are focusing on developing next-generation canal-based glaucoma surgery devices to offer minimally invasive options and address the growing demand for safer, more efficient treatments. Canal-based glaucoma surgery devices are implants that target the Schlemm's canal to enhance aqueous humor drainage, reducing intraocular pressure (IOP). This helps manage glaucoma by addressing the primary cause of the condition's progression. For instance, in March 2023, Nova Eye Medical Limited, an Australia-based glaucoma devices manufacturer, received clearance for its iTrack Advance canaloplasty device. This innovative device is engineered for microcatheterization and viscodilation to reduce intraocular pressure (IOP) in adult patients with primary open-angle glaucoma. The iTrack Advance is equipped with an ergonomic handpiece and enhanced technology to improve surgical efficiency. It is designed for both standalone procedures and those performed in conjunction with cataract surgery.

Regional Outlook

North America was the largest region in the glaucoma drainage devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Glaucoma Drainage Devices Market?

The glaucoma drainage devices market consists of sales of glaucoma valves, drainage tubes, and associated medical accessories or tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.